SCHEMBL9512401

SCHEMBL9512401

CCOC(=O)C1([C@H](CO)NC(=O)OC(C)(C)C)CC1

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
HTT P42858 1/20 0.41
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA7 P43166 1/20 0.37
ALDH1A1 P00352 2/20 0.37
MAPT P10636 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
CTSL P07711 2/20 0.36
APLNR P35414 1/20 0.35
CTSK P43235 6/20 0.35
CTSS P25774 2/20 0.35
CYP2D6 P10635 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29255570 1.00 CYP1A2 (0.41) CYP1A2CYP2C9CYP2C19HTTCA1
SCHEMBL10434800 0.80 MAPK1 (0.39) SMN1; SMN2
SCHEMBL7865687 0.78 CTSK (0.42) CYP1A2CYP2C9CYP2C19HTTCA1
SCHEMBL29254920 0.77 PPARA (0.53) CTSLCTSKCTSS
SCHEMBL4555890 0.75 CTSK (0.46) CA1CA2CA7CTSLAPLNR
SCHEMBL26656068 0.74 CA1 (0.41) CYP1A2CYP2C9CYP2C19HTTCA1
SCHEMBL26656061 0.74 CA1 (0.41) CYP1A2CYP2C9CYP2C19HTTCA1
SCHEMBL8211606 0.71 CYP1A2 (0.62) CYP1A2CYP2C9CYP2C19HTTCA1
SCHEMBL5147736 0.71 CYP1A2 (0.62) CYP1A2CYP2C9CYP2C19HTTCA1
SCHEMBL16245194 0.71 CYP1A2 (0.54) CYP1A2CYP2C9CYP2C19HTTCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0363994-B1 (2R,3S,4S)-ALPHA-(CARBOXYCYCLOPROPYL)GLYCINE SUNTORY LIMITED (JP) 1993-09-22 EP disclosed
US-5068412-A Nervous system disorders such as treatment of epilepsy or Huntington's chorea SUNTORY LIMITED (JP) 1991-11-26 US disclosed